Stryker recently unveiled its T2 Alpha Humerus Nailing System, expanding its orthopedic offerings. The company also initiated a limited market release for its Mako RPS handheld robotic system, designed for total knee replacement procedures. This innovative Mako RPS system is expected to significantly broaden the application of robotic-assisted knee surgeries. Concurrently, Stryker reported robust financial performance for the full year 2025. The medical device giant achieved total sales of US$25.12 billion and a net income of US$3.25 billion. These strategic product introductions, coupled with strong earnings, reinforce Stryker's leadership in orthopedic robotics and signal a positive outlook for its future growth.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis